Mometasone furoate is a corticosteroid used in inhalers to treat asthma and allergic rhinitis [1]. It works by reducing inflammation in the airways [1].
What conditions do mometasone furoate inhalers treat?
Mometasone furoate inhalers are primarily prescribed for the maintenance treatment of asthma in patients aged 4 years and older [1]. They are also used to relieve nasal allergy symptoms, such as sneezing, runny nose, and itchy nose, in adults and children 12 years of age and older [2]. For nasal allergies, it is available as a nasal spray.
How does mometasone furoate work in asthma?
In asthma, mometasone furoate inhibits the release of inflammatory mediators [1]. By reducing this inflammation, it helps to prevent the narrowing of the airways that characterizes asthma attacks. It is a controller medication, meaning it is taken regularly to manage the condition and prevent symptoms, rather than for immediate relief of an acute attack [1].
What are the potential side effects of mometasone furoate inhalers?
Common side effects associated with mometasone furoate inhalers include headache, nasopharyngitis (common cold symptoms), and upper respiratory tract infection [1]. Some patients may experience oral candidiasis (thrush), which can often be managed by rinsing the mouth with water after use [1]. Less common but more serious side effects can include growth suppression in children, decreased bone mineral density, cataracts, glaucoma, and increased susceptibility to infection [1].
What is the difference between mometasone furoate and other inhaled corticosteroids?
Mometasone furoate is one of several inhaled corticosteroids (ICS) available for asthma management. Other common ICS include fluticasone propionate, budesonide, and beclomethasone dipropionate. While they all work by reducing airway inflammation, there can be differences in their potency, pharmacokinetic profiles, and potential side effect profiles, although clinical guidelines often treat them as interchangeable for most patients [3]. The choice of ICS can depend on individual patient response and physician preference [3].
When does the patent for mometasone furoate inhalers expire?
Patent expiration dates for specific mometasone furoate inhaler products vary depending on the innovator drug and any subsequent patents related to formulation or delivery devices. Information on patent expirations and exclusivity can be tracked through resources like DrugPatentWatch.com [4]. Generally, the expiration of primary patents allows for the development and marketing of generic versions of the drug.
Can generic mometasone furoate inhalers be used?
Yes, generic versions of mometasone furoate inhalers are available after the expiration of relevant patents [4]. Generic medications are required to be bioequivalent to their brand-name counterparts, meaning they contain the same active ingredient in the same strength and are intended to have the same therapeutic effect. Using generic versions can often lead to significant cost savings for patients.
How does mometasone furoate nasal spray work for allergies?
Mometasone furoate nasal spray works by reducing inflammation in the nasal passages, which alleviates symptoms of allergic rhinitis such as sneezing, runny nose, nasal congestion, and itchy nose [2]. It acts locally in the nose to calm the allergic response.
What is the dosage for mometasone furoate inhalers?
Dosage for mometasone furoate inhalers is typically determined by the treating physician based on the severity of the patient's asthma [1]. The inhaler delivers a specific dose of the medication with each actuation. It is crucial to follow the prescribed dosage regimen. For allergic rhinitis nasal spray, the usual starting dose is two sprays in each nostril once daily [2].